dc.contributor
Institut Català de la Salut
dc.contributor
[Della Camera G] Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Napoli, Italy. European Commission, Joint Research Centre (JRC), Ispra, Italy. [Liu T, Yang W, Li Y] Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), Shenzhen, China. China-Italy Joint Laboratory of Pharmacobiotechnology for Medical Immunomodulation (CNR, SIAT, SZN), SIAT, CAS, Shenzhen, China. [Puntes VF] Institut Català de Nanociència i Nanotecnologia (ICN2), Consejo Superior de Investigaciones Científicas (CSIC) and The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain. [Gioria S] European Commission, Joint Research Centre (JRC), Ispra, Italy. [Italiani P] Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Napoli, Italy. Stazione Zoologica Anton Dohrn (SZN), Napoli, Italy. China-Italy Joint Laboratory of Pharmacobiotechnology for Medical Immunomodulation (CNR, SIAT, SZN), IBBC, CNR, Napoli, Italy. [Boraschi D] Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Napoli, Italy. Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), Shenzhen, China. China-Italy Joint Laboratory of Pharmacobiotechnology for Medical Immunomodulation (CNR, SIAT, SZN), SIAT, CAS, Shenzhen, China. Stazione Zoologica Anton Dohrn (SZN), Napoli, Italy. China-Italy Joint Laboratory of Pharmacobiotechnology for Medical Immunomodulation (CNR, SIAT, SZN), IBBC, CNR, Napoli, Italy
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Della Camera, Giacomo
dc.contributor.author
Liu, Tinghao
dc.contributor.author
Yang, Wenjie
dc.contributor.author
Li, Yang
dc.contributor.author
Franco Puntes, Victor
dc.contributor.author
Gioria, Sabrina
dc.contributor.author
Italiani, Paola
dc.contributor.author
Boraschi, Diana
dc.date.accessioned
2025-10-24T08:51:02Z
dc.date.available
2025-10-24T08:51:02Z
dc.date.issued
2022-12-28T12:02:46Z
dc.date.issued
2022-12-28T12:02:46Z
dc.identifier
Della Camera G, Liu T, Yang W, Li Y, Puntes VF, Gioria S, et al. Induction of Innate Memory in Human Monocytes Exposed to Mixtures of Bacterial Agents and Nanoparticles. Int J Mol Sci. 2022 Dec;23(23):14655.
dc.identifier
https://hdl.handle.net/11351/8716
dc.identifier
10.3390/ijms232314655
dc.identifier.uri
http://hdl.handle.net/11351/8716
dc.description.abstract
Innate memory; Macrophages; Monocytes
dc.description.abstract
Memoria innata; Macrófagos; Monocitos
dc.description.abstract
Memòria innata; Macròfags; Monòcits
dc.description.abstract
We assessed whether concomitant exposure of human monocytes to bacterial agents and different engineered nanoparticles can affect the induction of protective innate memory, an immune mechanism that affords better resistance to diverse threatening challenges. Monocytes were exposed in vitro to nanoparticles of different chemical nature, shape and size either alone or admixed with LPS, and cell activation was assessed in terms of production of inflammatory (TNFα, IL-6) and anti-inflammatory cytokines (IL-10, IL-1Ra). After return to baseline conditions, cells were re-challenged with LPS and their secondary “memory” response measured. Results show that nanoparticles alone are essentially unable to generate memory, while LPS induced a tolerance memory response (less inflammatory cytokines, equal or increased anti-inflammatory cytokines). LPS-induced tolerance was not significantly affected by the presence of nanoparticles during the memory generation phase, although with substantial donor-to-donor variability. This suggests that, despite the overall lack of significant effects on LPS-induced innate memory, nanoparticles may have donor-specific effects. Thus, future nanosafety assessment and nanotherapeutic strategies will need a personalized approach in order to ensure both the safety and efficacy of nano medical compounds for individual patients.
dc.description.abstract
This work was supported by the EU Commission H2020 projects PANDORA (GA671881) and ENDONANO (GA 812661) (PI, DB), the Italian MIUR InterOmics Flagship projects MEMORAT and MAME (DB, PI), and the Presidential International Fellowship Program (PIFI) of the Chinese Academy of Science (2020VBA0028) (DB). Part of this work was carried out in the context of the JRC Visiting Scientist agreement no. 05/JRC.F.2/2019 (Directorate F—Health, Consumers and Reference Materials, Consumer Products Safety, Nanobiotechnology Lab).
dc.format
application/pdf
dc.relation
International Journal of Molecular Sciences;23(23)
dc.relation
https://doi.org/10.3390/ijms232314655
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Nanopartícules
dc.subject
Immunitat natural
dc.subject
TECHNOLOGY, INDUSTRY, AND AGRICULTURE::Technology, Industry, and Agriculture::Manufactured Materials::Nanostructures::Nanoparticles
dc.subject
PHENOMENA AND PROCESSES::Immune System Phenomena::Immunity::Immunity, Innate
dc.subject
TECNOLOGÍA, INDUSTRIA Y AGRICULTURA::tecnología, industria y agricultura::productos manufacturados::nanoestructuras::nanopartículas
dc.subject
FENÓMENOS Y PROCESOS::fenómenos del sistema inmunitario::inmunidad::inmunidad innata
dc.title
Induction of Innate Memory in Human Monocytes Exposed to Mixtures of Bacterial Agents and Nanoparticles
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion